Materials and methods for identifying gyrase inhibitors

US10000807B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10000807-B2
Application numberUS-201615254553-A
CountryUS
Kind codeB2
Filing dateSep 1, 2016
Priority dateSep 1, 2016
Publication dateJun 19, 2018
Grant dateJun 19, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The disclosure describes the effects of transcription mediated from a promoter on the transcription mediated by divergently coupled supercoiling-sensitive promoter. Transcription initiated from a promoter inhibits transcription mediated by a specific supercoiling-sensitive promoter that is divergently coupled to the promoter. A gyrase inhibitor relieves this inhibition and substantially increases the transcription mediated by the specific supercoiling-sensitive promoter that is divergently coupled to another promoter. Accordingly, the invention pertains to a method for identifying a compound as a gyrase inhibitor or not a gyrase inhibitor based on differential expression of genes under the control of divergently coupled promoters in the presence of the compound. Another embodiment of the invention provides an assay for identifying one or more compounds from a library of compounds as a gyrase inhibitor. Polynucleotides and cells containing such polynucleotides that are suitable for carrying out the methods described herein are also provided.

First claim

Opening claim text (preview).

We claim: 1. A linear DNA construct comprising: i) a first inducible promoter under the control of an inducer and operably linked to a first gene and at least one terminator, and ii) a second promoter operably linked to a second gene; wherein the first promoter is P T7lac , P trc , P lac , P T7A1/O4 , P lacUV5 , P rhaBAD , P ara , P tetA , P recA , P phoA , P trp , P nar , P PL , P espA , P proU , or P est-4 and the second promoter is P gyrA or P gyrB ; wherein the second promoter is divergently coupled to the first promoter such that: a) the first promoter is located between the second promoter and the first gene; b) the second promoter is located between the first promoter and the second gene; c) at least the first promoter is heterologous to the first gene or the second promoter is heterologous to the second gene; and d) no additional promoter is positioned between the first promoter and the second promoter; wherein, when the linear DNA construct is incorporated in a linear or circular DNA vector or into genomic DNA in a prokaryotic host cell, the first and the second promoters initiate transcription in opposite directions to each other; transcription of the first gene under the control of the first promoter causes negative supercoiling of the second promoter; and said negative supercoiling of the second promoter inhibits transcription of the second gene from the second promoter. 2. The DNA construct of claim 1 , wherein the DNA construct further comprises one or more of: a terminator for the second gene, a selectable marker, an origin of replication for replication in a prokaryotic cell and/or a eukaryotic cell, and a multiple cloning site. 3. The DNA construct of claim 1 , wherein the first gene encodes for a first peptide and the second gene encodes for a second peptide. 4. The DNA construct of claim 1 , wherein only the first gene or only the second gene encodes for a marker protein. 5. A cell or a culture of the cell, wherein the cell comprises the DNA construct of claim 1 . 6. The cell of claim 5 , wherein the cell is a prokaryotic cell. 7. The cell of claim 5 , wherein the construct is incorporated into extra-chromosomal genetic material. 8. The cell of claim 5 , wherein the construct is integrated into the genome of the cell. 9. A linear NA construct comprising: i) a first promoter operably linked to a first gene, and ii) a second promoter operably linked to a second gene; wherein the first promoter is P T7lac , P lac , P T7A1/O4 , or P laCUV5 , and the second promoter is P gyrA or P gyrB ; wherein the second promoter is divergently coupled to the first promoter such that: a) the first promoter is located between the second promoter and the first gene; b) the second promoter is located between the first promoter and the second gene; c) at least the first promoter is heterologous to the first gene or the second promoter is heterologous to the second gene; and d) no additional promoter is positioned between the first promoter and the second promoter; wherein, when the linear DNA construct is incorporated in a linear or circular DNA vector or into genomic DNA in a prokaryotic host cell, the first and the second promoters initiate transcription in opposite directions to each other; transcription of the first gene under the control of the first promoter causes negative supercoiling of the second promoter; and said negative supercoiling of the second promoter inhibits transcription of the second gene from the second promoter. 10. The DNA construct according to claim 1 , wherein the first promoter is separated by no more than 92 bp from the second promoter. 11. The DNA construct according to claim 9 , wherein the first promoter is separated by no more than 92 bp from the second promoter.

Assignees

Inventors

Classifications

  • C12N9/90Primary

    Isomerases (5.) · CPC title

  • on expression patterns · CPC title

  • DNA topoisomerase (ATP-hydrolysing) (5.99.1.3) · CPC title

  • involving isomerase · CPC title

  • for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics (antimicrobial activity C12Q1/18) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10000807B2 cover?
The disclosure describes the effects of transcription mediated from a promoter on the transcription mediated by divergently coupled supercoiling-sensitive promoter. Transcription initiated from a promoter inhibits transcription mediated by a specific supercoiling-sensitive promoter that is divergently coupled to the promoter. A gyrase inhibitor relieves this inhibition and substantially increas…
Who is the assignee on this patent?
Leng Fenfei, Zhi Xiaoduo, Dages Samantha, and 2 more
What technology area does this patent fall under?
Primary CPC classification C12N9/90. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 19 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).